ROXALL Medizin GmbH

ROXALL is an international active pharmaceutical company based in Hamburg, Germany. The main focus is the development, production and distribution of products in the field of allergology, immunology and emergency medicine. With innovations in specific immunotherapy (SIT) ROXALL significantly simplified the therapy of allergic diseases. The cluster immunotherapy represents a time-saving injection therapy and with a perlingual spray application patients are able to perform therapy at home. With CLUSTO-Prick a quick and easy-to-use medical device for in-vivo diagnostic of allergic diseases is available. In combination with CLUSTO-Prick ROXALL proudly presents the first automated system for skin prick test – PRIXI.